ATHIRA PHARMA INC's ticker is ATHA and the CUSIP is 04746L104. A total of 106 filers reported holding ATHIRA PHARMA INC in Q2 2022. The put-call ratio across all filers is 0.31 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $671,000 | -93.1% | 220,000 | -69.3% | 0.12% | -90.2% |
| Q1 2022 | $9,683,000 | -54.4% | 717,285 | -56.0% | 1.26% | -42.7% |
| Q4 2021 | $21,249,000 | +22.1% | 1,630,744 | -12.1% | 2.19% | +74.6% |
| Q3 2021 | $17,408,000 | +20.5% | 1,855,812 | +31.5% | 1.26% | +3.4% |
| Q2 2021 | $14,447,000 | -22.3% | 1,410,812 | +39.6% | 1.21% | -33.1% |
| Q1 2021 | $18,599,000 | -42.7% | 1,010,812 | +6.6% | 1.82% | -34.8% |
| Q4 2020 | $32,465,000 | +72.3% | 947,873 | -7.1% | 2.78% | +15.4% |
| Q3 2020 | $18,844,000 | – | 1,020,812 | – | 2.41% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| AWH Capital, L.P. | 230,000 | $351,351 | 0.48% |
| Perceptive Advisors | 4,797,278 | $14,632,000 | 0.46% |
| Ikarian Capital, LLC | 784,200 | $2,393,000 | 0.44% |
| Bristlecone Advisors, LLC | 700,926 | $2,138,000 | 0.26% |
| Altium Capital Management LP | 200,100 | $610,000 | 0.24% |
| RA Capital Management | 1,878,000 | $5,728,000 | 0.15% |
| Logos Global Management LP | 220,000 | $671,000 | 0.12% |
| PATHSTONE FAMILY OFFICE, LLC | 1,688,840 | $5,150,963 | 0.11% |
| Ikarian Capital, LLC | 199,500 | $609,000 | 0.11% |
| SG3 Management, LLC | 206,000 | $628,000 | 0.07% |